List of works - Christian Beyer

Activation of pregnane X receptor inhibits experimental dermal fibrosis

scientific article published on 4 January 2013

Anti-interleukin 6 receptor therapy as rescue treatment for giant cell arteritis

scientific article published on 24 April 2011

Autophagy regulates TNFα-mediated joint destruction in experimental arthritis.

scientific article

Blockade of canonical Wnt signalling ameliorates experimental dermal fibrosis

scientific article published on 17 April 2013

Can ANCA differentiate eosinophilic granulomatosis with polyangiitis (Churg-Strauss) from idiopathic hypereosinophilic syndrome?

Changing paradigms in spondylarthritis: the myofibroblast signature

scientific article published on 01 January 2013

EUSTAR biobanking: recommendations for the collection, storage and distribution of biospecimens in scleroderma research

scientific article published in February 2011

IgG4 immune response in Churg-Strauss syndrome

scientific article published on 25 November 2011

Inactivation of fatty acid amide hydrolase exacerbates experimental fibrosis by enhanced endocannabinoid-mediated activation of CB1

scientific article published on 22 August 2012

Inactivation of tankyrases reduces experimental fibrosis by inhibiting canonical Wnt signalling

scientific article published on 12 November 2012

Inactivation of the transcription factor STAT-4 prevents inflammation-driven fibrosis in animal models of systemic sclerosis

scientific article published on 01 March 2011

Inhibition of H3K27 histone trimethylation activates fibroblasts and induces fibrosis

scientific article published on 21 August 2012

Inhibition of Notch signaling prevents experimental fibrosis and induces regression of established fibrosis.

scientific article published on May 2011

Inhibition of activator protein 1 signaling abrogates transforming growth factor β-mediated activation of fibroblasts and prevents experimental fibrosis.

scientific article published in May 2012

Inhibition of glycogen synthase kinase 3β induces dermal fibrosis by activation of the canonical Wnt pathway.

scientific article

Inhibition of hedgehog signaling for the treatment of murine sclerodermatous chronic graft-versus-host disease

scientific article published on 22 August 2012

Inhibition of hedgehog signalling prevents experimental fibrosis and induces regression of established fibrosis

scientific article published on 08 March 2012

Inhibition of sumoylation prevents experimental fibrosis

scientific article published on 17 August 2012

Innovative antifibrotic therapies in systemic sclerosis.

scientific article published on May 2012

JAK-2 as a novel mediator of the profibrotic effects of transforming growth factor β in systemic sclerosis.

scientific article

Jun N-terminal kinase as a potential molecular target for prevention and treatment of dermal fibrosis.

scientific article

Liver X receptors orchestrate osteoblast/osteoclast crosstalk and counteract pathologic bone loss

scientific article published on 19 November 2012

Modeling nuclear molecule release during in vitro cell death.

scientific article published on 16 January 2013

Morphogen Pathways in Systemic Sclerosis ⬇️

scientific article published on January 1, 2013

Morphogen pathways as molecular targets for the treatment of fibrosis in systemic sclerosis ⬇️

scientific article published on December 4, 2012

Notch signalling regulates fibroblast activation and collagen release in systemic sclerosis

scientific article published on 30 March 2011

Platelet-derived serotonin links vascular disease and tissue fibrosis

scientific article

Pomalidomide is effective for prevention and treatment of experimental skin fibrosis

scientific article published on 17 August 2012

Stimulation of soluble guanylate cyclase reduces experimental dermal fibrosis

scientific article published on 30 January 2012

Strawberry gingivitis

scientific article published on 04 February 2012

The Wnt antagonists DKK1 and SFRP1 are downregulated by promoter hypermethylation in systemic sclerosis

scientific article published on 22 May 2013

The extracellular release of DNA and HMGB1 from Jurkat T cells during in vitro necrotic cell death

scientific article published on 16 February 2012

The prostaglandin E(2) system: a toolbox for skeletal repair?

scientific article published on 01 April 2011

The role of microparticles in the pathogenesis of rheumatic diseases.

scientific article published on December 2009

The scientific basis for novel treatments of systemic sclerosis

scientific article published on 9 December 2009

Tyrosine kinase signaling in fibrotic disorders: Translation of basic research to human disease.

scientific article

β-catenin is a central mediator of pro-fibrotic Wnt signaling in systemic sclerosis ⬇️

scientific article published on February 10, 2012

List of works by Christian Beyer

Activation of pregnane X receptor inhibits experimental dermal fibrosis

Anti-interleukin 6 receptor therapy as rescue treatment for giant cell arteritis

Autophagy regulates TNFα-mediated joint destruction in experimental arthritis.

Blockade of canonical Wnt signalling ameliorates experimental dermal fibrosis

Can ANCA differentiate eosinophilic granulomatosis with polyangiitis (Churg-Strauss) from idiopathic hypereosinophilic syndrome?

Changing paradigms in spondylarthritis: the myofibroblast signature

EUSTAR biobanking: recommendations for the collection, storage and distribution of biospecimens in scleroderma research

IgG4 immune response in Churg-Strauss syndrome

Inactivation of fatty acid amide hydrolase exacerbates experimental fibrosis by enhanced endocannabinoid-mediated activation of CB1

Inactivation of tankyrases reduces experimental fibrosis by inhibiting canonical Wnt signalling

Inactivation of the transcription factor STAT-4 prevents inflammation-driven fibrosis in animal models of systemic sclerosis

Inhibition of H3K27 histone trimethylation activates fibroblasts and induces fibrosis

Inhibition of Notch signaling prevents experimental fibrosis and induces regression of established fibrosis.

Inhibition of activator protein 1 signaling abrogates transforming growth factor β-mediated activation of fibroblasts and prevents experimental fibrosis.

Inhibition of glycogen synthase kinase 3β induces dermal fibrosis by activation of the canonical Wnt pathway.

Inhibition of hedgehog signaling for the treatment of murine sclerodermatous chronic graft-versus-host disease

Inhibition of hedgehog signalling prevents experimental fibrosis and induces regression of established fibrosis

Inhibition of sumoylation prevents experimental fibrosis

Innovative antifibrotic therapies in systemic sclerosis.

JAK-2 as a novel mediator of the profibrotic effects of transforming growth factor β in systemic sclerosis.

Jun N-terminal kinase as a potential molecular target for prevention and treatment of dermal fibrosis.

Liver X receptors orchestrate osteoblast/osteoclast crosstalk and counteract pathologic bone loss

Modeling nuclear molecule release during in vitro cell death.

Morphogen Pathways in Systemic Sclerosis ⬇️

Morphogen pathways as molecular targets for the treatment of fibrosis in systemic sclerosis ⬇️

Notch signalling regulates fibroblast activation and collagen release in systemic sclerosis

Platelet-derived serotonin links vascular disease and tissue fibrosis

Pomalidomide is effective for prevention and treatment of experimental skin fibrosis

Stimulation of soluble guanylate cyclase reduces experimental dermal fibrosis

Strawberry gingivitis

The Wnt antagonists DKK1 and SFRP1 are downregulated by promoter hypermethylation in systemic sclerosis

The extracellular release of DNA and HMGB1 from Jurkat T cells during in vitro necrotic cell death

The prostaglandin E(2) system: a toolbox for skeletal repair?

The role of microparticles in the pathogenesis of rheumatic diseases.

The scientific basis for novel treatments of systemic sclerosis

Tyrosine kinase signaling in fibrotic disorders: Translation of basic research to human disease.

β-catenin is a central mediator of pro-fibrotic Wnt signaling in systemic sclerosis ⬇️